High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

Additional Metadata
Persistent URL	dx.doi.org/10.1093/annonc/mdy270.184, hdl.handle.net/1765/125530
Journal	Annals of Oncology
Organisation	Erasmus MC Cancer Institute
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Steenbruggen, T.G. (T. G.), Steggink, L.C. (L. C.), Seynaeve, C.M, van der Hoeven, J, Hooning, M.J. (M. J.), Jager, A, … Gietema, J.A. (2018). High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study. Annals of Oncology, 29. doi:10.1093/annonc/mdy270.184

Publication